Orchestra BioMed Inc. (OBIO)

4.12

-0.57 (-12.15%)

At close: Mar 03, 2025, 3:59 PM

4.10

-0.49%

After-hours: Mar 03, 2025, 04:00 PM EST

Orchestra BioMed Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20
Net Income	-49.12M	-33.61M	-23.01M	-21.36M
Depreciation & Amortization	287K	222K	181K	137K
Stock-Based Compensation	7.63M	3.41M	302K	221K
Other Working Capital	-3.58M	-451K	1.47M	-5.41M
Other Non-Cash Items	-1.61M	4.77M	217K	2.93M
Deferred Income Tax	n/a	-3.63M	288K	n/a
Change in Working Capital	-3.31M	-451K	2.6M	-8.12M
Operating Cash Flow	-46.13M	-29.29M	-19.43M	-26.18M
Capital Expenditures	-78K	-591K	-274K	-539K
Acquisitions	n/a	-29.06M	-13.29M	-27.5M
Purchase of Investments	-142.03M	-63.53M	-213K	-15.62M
Sales Maturities Of Investments	152.8M	92.59M	13.5M	43.13M
Other Investing Acitivies	n/a	-63.53M	13.29M	27.5M
Investing Cash Flow	10.69M	-64.12M	13.02M	26.97M
Debt Repayment	-10.85M	3.55M	-4M	10M
Common Stock Repurchased	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	57.06M	-10.13M	7K	n/a
Financial Cash Flow	46.22M	103.26M	-3.99M	10M
Net Cash Flow	10.78M	18.03M	-10.4M	10.78M
Free Cash Flow	-46.2M	-29.88M	-19.7M	-26.72M